Menu Back toSession-4-Japan-and-Asia-Updates

Global Labeling Conference


Session 4: Japan and Asia Updates

    Session Chair(s)
      Rie  Matsui, RPh

      Rie Matsui, RPh

      • Director, Regional Labeling Head for Asia, International Labeling Group
      • Pfizer Japan Inc., Japan
    Japanese labels must be updated according to the new regulations, and necessary preparations for the potential impact of the new regulation on global labeling will be discussed. This session will also provide PMDA initiatives in Asia and updates on important labeling-related regulatory trends in Asia, including China, Singapore, Korea, and Vietnam.
    Learning Objective : At the conclusion of this session, participants should be able to:
    • Describe the new labeling regulations for Japan and how to prepare for the revision
    • Discuss the impact of the new labeling regulations for Japan on global labeling
    • Discuss PMDA initiatives and regulatory trends related to labeling in Asia
    Speaker(s)
      Shinobu  Uzu, MSc

      New Labeling Regulations in Japan and PMDA Initiatives in Asia

      Shinobu Uzu, MSc

      • Associate Executive Director
      • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
      Rie  Matsui, RPh

      Labeling in Asia: A Dynamic Landscape

      Rie Matsui, RPh

      • Director, Regional Labeling Head for Asia, International Labeling Group
      • Pfizer Japan Inc., Japan
      Panel  Discussion

      Panel Discussion

      • All Session Speakers, United States
      Panel  Q&A

      Panel Q&A

      • United States